IOPIDINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Iopidine, and what generic alternatives are available?
Iopidine is a drug marketed by Harrow Eye and is included in two NDAs.
The generic ingredient in IOPIDINE is apraclonidine hydrochloride. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the apraclonidine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Iopidine
A generic version of IOPIDINE was approved as apraclonidine hydrochloride by RISING on March 12th, 2009.
Summary for IOPIDINE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 86 |
Clinical Trials: | 1 |
Patent Applications: | 381 |
Drug Prices: | Drug price information for IOPIDINE |
What excipients (inactive ingredients) are in IOPIDINE? | IOPIDINE excipients list |
DailyMed Link: | IOPIDINE at DailyMed |
Recent Clinical Trials for IOPIDINE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Alabama at Birmingham | Phase 4 |
Pharmacology for IOPIDINE
Drug Class | alpha-Adrenergic Agonist |
Mechanism of Action | Adrenergic alpha-Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for IOPIDINE
US Patents and Regulatory Information for IOPIDINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Harrow Eye | IOPIDINE | apraclonidine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 020258-001 | Jul 30, 1993 | AT | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Harrow Eye | IOPIDINE | apraclonidine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 019779-001 | Dec 31, 1987 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for IOPIDINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Harrow Eye | IOPIDINE | apraclonidine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 019779-001 | Dec 31, 1987 | ⤷ Try a Trial | ⤷ Try a Trial |
Harrow Eye | IOPIDINE | apraclonidine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 020258-001 | Jul 30, 1993 | ⤷ Try a Trial | ⤷ Try a Trial |
Harrow Eye | IOPIDINE | apraclonidine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 019779-001 | Dec 31, 1987 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for IOPIDINE
See the table below for patents covering IOPIDINE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | H0453846 | ⤷ Try a Trial | |
Germany | 3269242 | ⤷ Try a Trial | |
Canada | 1194418 | COMPOSITIONS A BASE DE 2-(PHENYLIMINO TRISUBSTITUE)- IMIDAZOLINE POUR L'ABAISSEMENT DE LA PRESSION INTRAOCULAIRE (2-(TRISUBSTITUTED PHENYLIMINO)-IMIDAZOLINE COMPOSITIONS FOR LOWERING INTRAOCULAR PRESSURE) | ⤷ Try a Trial |
European Patent Office | 0081924 | TOPICAL COMPOSTIONS FOR LOWERING INTRAOCULAR PRESSURE | ⤷ Try a Trial |
Canada | 1201066 | SOLUTIONS DE N-[3,5-DICHLORO-4-(2- IMIDAZOLIDINYLIDENE-AMINO)-PHENYL]-ACETAMIDE POUR DIMINUER LA PRESSION INTRA-OCULAIRE (N-[3,5-DICHLORO-4-(2-IMIDAZOLIDINYLIDENEAMINO)- PHENYL]-ACETAMIDE SOLUTIONS FOR LOWERING INTRAOCULAR PRESSURE) | ⤷ Try a Trial |
Netherlands | 950008 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for IOPIDINE
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0081924 | SPC/GB93/103 | United Kingdom | ⤷ Try a Trial | SPC/GB93/103:, EXPIRES: 20071118 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |